Effectiveness of electronic cigarettes for smoking substitution

Similar documents
Effectiveness of electronic cigarettes for smoking substitution

Electronic Cigarettes and the Medical Society

Experimental trial on the effectiveness of IQOS compared to e-cigarettes and regular tobacco cigarettes

Health Effects of Electronic Nicotine Delivery Systems: A Systematic Review

The Relationship between E-cigarette Use and Tobacco Status among Youth in Public Health Tobacco Cessation Programs

Do Electronic Cigarettes Have Any Potential for Smoking Cessation? Professor Chris Bullen MBChB, MPH, PhD SRNT Webinar December 8th 2016

Use of e-cigarettes (vapourisers) among adults in Great Britain

Electronic cigarettes for smoking cessation

E-cigarettes in Europe : a consumer led revolution

Non-Industry Voices on Tobacco Harm Reduction and Vaping Products

Might Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re

Public Health England s Independent Expert E-Cigarettes Evidence Review

Quit and Smoking Reduction Rates in Vape Shop Consumers: A Prospective 12-Month Survey

Marketing a healthier choice: Exploring young people s perception of e-cigarettes

Electronic Nicotine Delivery Systems

Electronic Cigarettes: What we know so far

ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE?

The gateway theory. Pr Jean-François ETTER PhD (political science) E-cigarette Summit London, November 17, Competing interests: none

Using the Balanced-Placebo Design for Parsing Nicotine Administration Effects

Smoking, e-cigs and reduced risk products. Dr John Schoonbee, IMS November 2017

The U.S. Food and Drug Administration has

e-cigarette impact on Public Health

Comparing the Cochrane review of electronic cigarettes to other meta-analyses

American Vaping Association

CREATING A TOBACCO-FREE GENERATION A Tobacco Control Strategy for Scotland. Dr Catherine Calderwood Chief Medical Officer For Scotland

Smoking Cessation. Hassan Sajjad Pulmonary & Critical Care

HHS Public Access Author manuscript J Patient Cent Res Rev. Author manuscript; available in PMC 2016 February 04.

Use of electronic cigarettes (vapourisers) among adults in Great Britain

Working towards a smoke-free England

Helping Smokers to Quit in General Practice

E.cigarettes. An alternative to a uniquely deadly product that kills one in two of its regular users? Paul Lambert Public Health, Leeds City Council

Electronic cigarettes disruptive innovation, public health potential and regulatory challenge

Safety/risk assessment of electronic cigarettes

Melodie Tilson, Director of Policy

Global E-Cigarette Market- Industry Analysis & Outlook ( )

Communicating the Risk of Nicotine Delivery Products

R. Polosa COI last 5 yrs

Electronic Nicotine Delivery Systems: Patterns of Use and Disparities

The Evidence on E-cigarettes: Evaluating What We Have and Identifying What We Need

Priorities for Vaping Research: An Update

Using evidence to negotiate new policies on harm reduction

E cigarettes: how can research inform public policy?

REGULATORY OPTIONS FOR MOVING TO THE ELIMINATION OF SMOKING. Ron Borland PhD

SAFETY E-CIGS: CLINICAL STUDIES

July 2, RE: Docket No. FDA-2014-N Dear Dr. Ostroff:

E-cigarettes and personal vapourisers: current research and policy

Exploring five common claims about e-cigarette use. Lion Shahab, PhD University College

Smoking Reduction is the First Step Towards Smoking Cessation

Tobacco Cessation, E- Cigarettes and Hookahs

E cigarette History. Disclosure. Objectives. Rises in E cigarette Use. A Cloud of Controversy: E Cigarettes for Smoking Cessation

BASIC SKILLS FOR WORKING WITH SMOKERS

Varenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks?

How best to get your patients to stop smoking. Dr Alex Bobak GP and GPSI in Smoking Cessation Wandsworth, London

Nicotine & Tobacco Research Advance Access published October 30, 2014

Tobacco Control Tūranga Update Focus on reducing nicotine content in tobacco to help smokers quit

A combination of licensed medication and professional support is four times more likely to achieve a stop in smoking behaviour.

00:08 For decades our scientists have endeavoured to reduce the risks of tobacco use and continue to do so today. 00:15

Introduction. Principles

An Evolving Perspective on Smoking Cessation Therapies

BASIC SKILLS FOR WORKING WITH SMOKERS

Can E-cigarettes Help Curb the Smoking Epidemic in China?

Coach on Call. Thank you for your interest in E-Cigarettes: Your Questions Answered. I hope you find this tip sheet helpful.

Modeling of E-cigarette Use. David Levy, PhD Georgetown University

E-CIGARETTES CANCER INSIGHT WHAT YOU NEED TO KNOW ABOUT FOR PRACTICE NURSES. INSIDE: A3 poster to display in your practice.

EXPLORING THE EVIDENCE: THE ROLE OF E-CIGARETTES IN SMOKING CESSATION

E-CIGARETTES CANCER INSIGHT WHAT YOU NEED TO KNOW ABOUT. FOR GPs. INSIDE: A3 poster to display in your practice. October Created by Freepik

Centre for Addictive Behaviours Research. Attitudes to tobacco and e- cigarettes, e-cig ads and ASMs

Implementing the July 2015 NICE Quality Standard to reduce harm from smoking

Perceived relative harm of e cigarettes and attitudes towards their availability, advertising and use: A longitudinal survey

12 Vaping Stats & Trends for the Informed E-Cig Retailer

E-cigarette Use Related to Demographic Factors in Hawai i

Tobacco dependence: Implications for service provision

E-liquid Questions. Will you charge more for the 10ml pre-mixed bottles? No, we will try to keep our pricing structure as close to current as we can.

Position Statement Electronic cigarettes (e-cigarettes)

E-cigarettes: Evidence, perceptions and misconceptions. Martin Dockrell, Tobacco Control Programme Lead

Pharmacological Treatments for Tobacco Users with Behavioral Health Conditions

Pharmacotherapy for Tobacco Dependence Treatment

Primary Care Smoking Cessation. GP and Clinical Director WRPHO Primary Care Advisor MOH Tobacco Team Target Champion Primary Care Tobacco

Module 5. The Epidemiological Basis of Randomised Controlled Trials. Landon Myer School of Public Health & Family Medicine, University of Cape Town

Electronic cigarettes: A new era for tobacco harm reduction Adapted for SW Specialist Nurses for Children in Care meeting 17 January 2017

Int. J. Environ. Res. Public Health 2014, 11, ; doi: /ijerph OPEN ACCESS

Nicotine pharmacokinetics of electronic cigarettes: experimental data and a review of the literature

The English experience in a European regulatory context. E-cigarette summit Washington DC 1 st May 2018 Deborah Arnott Chief Executive ASH (UK)

Tobacco Use Dependence and Approaches to Treatment

the high CVD risk smoker

Smoking Cessation A Clinicians Perspective. Jeff Wilson, MD

Evaluation of ASC. Asian Smokefree Communities Pilot. Six Month Smoking Cessation Outcomes

E-CIGARETTES: THREAT OR OPPORTUNITY? Anna B Gilmore (1) Greg Hartwell (2)

The New Zealand experience with electronic cigarettes

Electronic Cigarettes

E-Cigarette Vaping: The Good, the Bad and the Ugly

OLDER PEOPLE SMOKING CESSATION PROGRAMME

Treating Tobacco Use:

Trends in electronic cigarette use in England

Does cigarette reduction while using nicotine replacement predict quitting? Observational evidence from the Rapid Reduction Trial

Vape to break the smoking habit

Nicotine Reduction: Harm Reduction not Prohibition

Population-level impact & reach

Electronic cigarettes for smoking cessation(review)

Transcription:

Effectiveness of electronic cigarettes for smoking substitution Prof. Dr. Frank Baeyens EU ENVI March 20th 2018 I have no competing financial interests, and I have no ties with the e-cig industry, nor with the tobacco industry, nor with pharma companies. I am an advocate for Tobacco Harm Reduction (THR) in general and for e-cig based THR in particular. I was a member of the e-cig advisory committee of the Superior Health Council (Belgium, 2015-16)

Setting the stage: Success rates with(out) quit-smoking assistance Smokers who choose to try quitting without any assistance ( willpower ): only 3 5 % abstinence 6 12 months later (Bauld et al., 2016) With medically approved smoking cessation aids and behavioural counseling: at best doubling or tripling of chances of long-term success (versus placebo) (JAMA) Stop-Smoking-Services (2012-2013) UK Data on over 3000 quit attempts Our results showed that the overall weighted carbon monoxide validated quit rate for clients at 52 weeks was 7.7%

Why it should work in theory: efficient nicotine delivery (Farsalinos et al., 2014) Nicotine flux (mg/s): wattage * mg/ml nic in e-liquid (Wagener et al., 2016)

Why it should work in theory: mimicry of sensory/behavioural characteristics (Adriaens et al., 2014) (Van Heel et al., 2017)

Does it work in practice? Self-reported quit rates in convenience samples of vapers (BE/NL) (Van Gucht et al., 2017) 83% quitters!

Does it work in practice? Self-reported quit rates in convenience samples of vapers (EU/USA) (Farsalinos et al., 2014) 81% quitters!

Caveat: Mere anecdotes? Selfselection? Arguably causal evidence that it works for some smokers Ostensible cause (e-cig use) and effect (quitting) both welldefined & observable Spontaneous cessation unlikely Experience of multiple failure now success Plausible mechanism (finding better substitute for smoking) BUT: enthusiastic vapers having most positive and success experience more likely to participate Selection bias Overestimation quit rate of target population Extrapolation to other populations / whole population of smokers? NO Causal inference justified? Did they quit because of using e-cigarettes?

Does it work in practice? RCTs Treat e-cig like medicine ( antibiotics test model ) Standardized type of e-cig, nicotine concentration, flavor, instructions, duration of use, dose, Randomized Controlled Trial No problem with selection bias and confounding Strongest causal inference

Does it work in practice? RCTs Smokers with no quit-intention 5 (8) month quit rate 37% (21%) (Adriaens et al., 2014)

Does it work in practice? RCTs Electronic cigarettes for smoking cessation: a randomised controlled trial (ASCEND). Bullen C Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N. Lancet. 2013 Nov 16;382(9905):1629-37. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. EffiCiency and Safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PloS One 2013;8(6):e66317. E-cig with nicotine better (9.3%) than placebo e-cig (4%) About equally effective (7.3%) as NRT(5.8%) But: inefficient and now obsolete 1st generation e-cigs

Does it work in practice? RCTs I beg to differ!

Does it work in practice? RCTs RCT gives only answer to a very specific question: If every patient who showed up at a clinic asking for treatment to quit smoking were given a particular e-cigarette device and liquid (or a choice among a short list) and a regimented set of instructions about using it (and no further social support), how many would be cured of smoking? (C.V. Phillips) Is this what we want to know? Medical intervention for average smoker vs. Effect of availability of e-cigarettes in the real world: Consumer product, use of which is guided by principles of: behavioural choice preference costs and benefits analysis Effectiveness co-determined by social support legal/policy context of vaping beliefs & knowledge about e-cigs and nicotine consumption personal aims openness to a low-risk substitute for smoking Importance of personalized experimentation ( controlled ) People who try vaping are selfselecting for having a betterthan-average chance it will work for them ( random(ized)) Does vaping promote smoking cessation among those who choose vaping, and however they choose to do it?

Tofu RCT Effect of providing meat substitutes on meat consumption All meat eaters (regardless of beliefs, preferences, social environment, personal aims ) Specific product, instructions for use, dose, time window Veggie meat substitutes prospective observational cohort study Those who self-select to try vs those who do not Friends who are veggie Belief these are healthy substitutes for meat Available nearby, attractive price Aim to find & use meat-substitute However they want, whatever they prefer

Prospective Observational Cohort Studies A cohort study compares smokers who (self-select to) use e-cigs in a quit attempt with those who do not, and assesses the association between exposure to e-cigs and abstinence from smoking. An optimal prospective observational study design : identify and follow a large cohort of smokers who want to quit or are making a quit attempt, assess e-cigarette exposure in detail before the smoking cessation outcome is assessed, biochemically confirm self-reported tobacco abstinence, and adjust for multiple potential confounding factors associated with e-cigarette use and with smoking cessation. Strength of observational studies: reflect the effectiveness of e-cigs as they are being used in real-world settings, rather than how a specific device would perform under controlled or optimal conditions. reflect how e-cigs are actually being used in the population, where they are consumer products sold without specific instructions to aid cessation. (NASEM)

Prospective cohort studies: overview

Conclusions of observational cohort studies Does vaping promote smoking cessation among those who choose vaping, and however they choose to do it? Causal inference justified? Would they have quit otherwise? Did they quit because of using e-cigarettes? Residual confounding possible/likely in some/most of these observational studies Yes: 20-52% quitters OR: 2.7-6 (vs. no e-cig) Conditional upon: Regular use Use of efficient e- cigarette In context of quitattempt

Population data: Great Britain Reach is high 35%! Impact = (efficacy * reach)

Population data: Great Britain (ASH, 2017) Over half of current e-cig users = quitters

Population data: France (Pasquereau et al., 2017) (Baromètre Santé 2016) 41% of current daily vapers in 2016 = quitters

Population data: Eurobarometer 2014 Smoking cessation due to e-cigarette use was reported by 35% of current e-cig users, while a further 32% reported smoking reduction Current daily users : 47% quitters Estimated 6.1 million quitters and an extra 9.2 million reducers in EU (Farsalinos et al., 2016, 2017)

Population data: Eurobarometer 2017 Estimated 7.5 million quitters and an extra 9.1 million reducers in EU